AGP Picks
View all

Bahamas STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bahamas STEM News.

Press releases published on June 29, 2026

George Medicines appoints Brendan Walsh as Senior Vice President of Supply Chain & Technical Operations
Field and Operations Teams Run Daily Work on Custom Power Apps
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
Sagimet Biosciences Joins the Russell 2000® and Russell 3000® Indexes
Vetty Named a 2026 North American Inspiring Workplace
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8:00 a.m. ET
Satellos Receives FDA Fast Track Designation for SAT-3247 for the Treatment of Duchenne Muscular Dystrophy
Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company
BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
Bitdeer Technologies Group Signs Colocation Lease Agreement for Tydal, Norway AI Data Center Site
NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer
Aurora Mobile's EngageLab Announces Launch of Silent Auth to Elevate Identity Verification for the Global Market
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
SeedX Launches Specialized B2B Fintech Marketing Services to Drive Predictable Revenue Growth
OwlTing Group (NASDAQ: OWLS) and Saber Money Open Settlement into India's US$860 Billion Export Economy
Growgent.ai Launches an AI Growth Engine for Small Businesses
Zymeworks to Acquire Theravance Biopharma, Inc.
Resalis Announces Initiation of Phase 1b Clinical Study  Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Bahamas STEM News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.